Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells
Authors
Keywords
Digalloylresveratrol, Ribonucleotide reductase, Pancreatic cancer, AsPC-1 cells, BxPC-3 cells
Journal
INVESTIGATIONAL NEW DRUGS
Volume 31, Issue 5, Pages 1115-1124
Publisher
Springer Nature
Online
2013-08-13
DOI
10.1007/s10637-013-0009-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Defining New Paradigms for the Treatment of Pancreatic Cancer
- (2011) Khaldoun Almhanna et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- (2011) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- A novel N-hydroxy-N′-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C)
- (2010) Philipp Saiko et al. BIOCHEMICAL PHARMACOLOGY
- Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest and inhibition of lymphendothelial gap formation in vitro
- (2010) S Madlener et al. BRITISH JOURNAL OF CANCER
- Human Papillomavirus16 Variant E7 Gene Induces Transformation of NIH 3T3 Cells Via Up-Regulation of cdc25A and Cyclin A
- (2010) Guifang Gao et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites
- (2010) Juma Hoshino et al. JOURNAL OF MEDICINAL CHEMISTRY
- MK-2206, an Allosteric Akt Inhibitor, Enhances Antitumor Efficacy by Standard Chemotherapeutic Agents or Molecular Targeted Drugs In vitro and In vivo
- (2010) H. Hirai et al. MOLECULAR CANCER THERAPEUTICS
- Antiproliferative effect of resveratrol in pancreatic cancer cells
- (2010) Jing Cui et al. PHYTOTHERAPY RESEARCH
- Cancer Statistics, 2009
- (2009) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- PIKKing on PKB: regulation of PKB activity by phosphorylation
- (2009) Lana Bozulic et al. CURRENT OPINION IN CELL BIOLOGY
- Short 42 C heat shock induces phosphorylation and degradation of Cdc25A which depends on p38MAPK, Chk2 and 14.3.3
- (2009) S. Madlener et al. HUMAN MOLECULAR GENETICS
- E2F4 and ribonucleotide reductase mediate S-phase arrest in colon cancer cells treated with chlorophyllin
- (2009) Korakod Chimploy et al. INTERNATIONAL JOURNAL OF CANCER
- Naphtho[1,2-b]furan-4,5-dione induces apoptosis and S-phase arrest of MDA-MB-231 cells through JNK and ERK signaling activation
- (2009) Kuei-Li Lin et al. TOXICOLOGY IN VITRO
- Digalloylresveratrol, a new phenolic acid derivative induces apoptosis and cell cycle arrest in human HT-29 colon cancer cells
- (2008) Astrid Bernhaus et al. CANCER LETTERS
- CDC25A Phosphatase: a Rate-Limiting Oncogene That Determines Genomic Stability
- (2008) D. Ray et al. CANCER RESEARCH
- Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells
- (2008) Astrid Bernhaus et al. INVESTIGATIONAL NEW DRUGS
- PKBα/Akt1 Acts Downstream of DNA-PK in the DNA Double-Strand Break Response and Promotes Survival
- (2008) Lana Bozulic et al. MOLECULAR CELL
- Resveratrol and its analogs: Defense against cancer, coronary disease and neurodegenerative maladies or just a fad?
- (2007) Philipp Saiko et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started